Als2 gene and amyotrophic lateral sclerosis type 2

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/12 (2006.01) A01K 67/027 (2006.01) A61K 31/7088 (2006.01) A61K 38/17 (2006.01) C07K 14/47 (2006.01) C07K 16/18 (2006.01) C12N 15/11 (2006.01) C12Q 1/68 (2006.01) G01N 33/53 (2006.01) G01N 33/68 (2006.01) A61K 38/00 (2006.01) A61K 48/00 (2006.01)

Patent

CA 2437960

Candidate gene causing Amyotrophic Lateral Sclerosis type 2 (ALS2), encoding a putative GTP exchange factor (GEF) or GTPase regulatory factor.

L'invention concerne un gène humain associé à la sclérose latérale amyotrophique de type 2 (SLA2). Le gène présent dans la région q33 du second chromosome. L'invention concerne également des versions mutantes du gène, ainsi que des acides nucléiques isolés dérivés du gène et des peptides codés par ces versions mutantes. L'invention concerne enfin des procédés de diagnostique de la SLA2.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Als2 gene and amyotrophic lateral sclerosis type 2 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Als2 gene and amyotrophic lateral sclerosis type 2, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Als2 gene and amyotrophic lateral sclerosis type 2 will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1660884

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.